Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

Become a partner
ALIENTRECTINIB
Rx
Cancer & Blood Disorders

ALIENTRECTINIB

Entrectinib
Generic (INN)
Entrectinib
Strength
100mg
Packaging
60 capsules/bottle
Indication
Targeted treatment for ROS1- or NTRK-positive cancers. (See package insert.)
Registration No.
11 L 1229/24
Package Insert
English & Lao (PDF)

More in Cancer & Blood Disorders

View all →
ALILAZTINI
ALILAZTINI
Lazertinib
ALILAROTINIB
ALILAROTINIB
Larotrectinib
ALIACATINIB
ALIACATINIB
Acalabrutinib
ALIDABRAFENIB
ALIDABRAFENIB
Dabrafenib
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Stem Cell CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Stem Cell Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文